WuXi AppTec released its performance for the first three quarters, with a net profit attributable to the parent company of 12.076 billion yuan, a year-on-year increase of 84.84%

WuXi AppTec released its Q3 2025 report, with revenue for the first three quarters reaching 32.857 billion yuan, a year-on-year increase of 18.61%; net profit attributable to the parent company was 12.076 billion yuan, a year-on-year increase of 84.84%. Revenue from the chemical business was 25.98 billion yuan, a year-on-year increase of 29.3%. Revenue from small molecule D&M business was 14.24 billion yuan, a year-on-year increase of 14.1%. The company continues to advance small molecule production capacity construction, expecting that by the end of 2025, the total volume of small molecule active pharmaceutical ingredient reactors will exceed 4,000 kL. TIDES business revenue also maintains rapid growth